Non Invasive Prenatal Testing (NIPT) Market

The report "Non-invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029", is projected to reach USD 14.1 billion by 2029 from USD 7.2 billion in 2024 at a CAGR of 14.5%.

Browse 506 market data Tables and 63 Figures spread through 370 Pages and in-depth TOC on "Non-invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

The non-invasive prenatal testing (NIPT) market is expanding due to several driving factors. One major factor is the increasing risk of chromosomal abnormalities associated with advancing maternal age. As women wait longer to have children, the likelihood of genetic issues rises, making NIPT a preferred option for early and accurate screening without the risks associated with invasive procedures. Additionally, many expectant mothers favor non-invasive methods because they are safer, more comfortable, and free from the potential complications of invasive tests like amniocentesis. Improved insurance coverage and reimbursement for NIPT also play a crucial role, as it makes the test more affordable and accessible to a broader audience. Furthermore, growing awareness through educational programs and public health campaigns is informing more people about the benefits and availability of NIPT, contributing to its increased adoption and market growth.

“Based on products and services, the services segment is expected to witness the fastest CAGR in the non-invasive prenatal testing (NIPT) market.”

In the forecast period, the services segment is expected to witness the fastest CAGR in the global non-invasive prenatal testing (NIPT) market. This high growth rate can be attributed to to the increasing demand for and reliance on specialized testing services offered by healthcare providers and laboratories. Unlike product-based solutions, which involve the sale of diagnostic kits and reagents, services encompass a comprehensive range of offerings including test administration, sample collection, genetic counseling, and result interpretation. This approach not only ensures higher accuracy and reliability of test results but also provides personalized support to expectant parents throughout the testing process. Additionally, the complexity and sensitivity of NIPT require professional expertise and advanced laboratory infrastructure, which drives healthcare institutions to outsource these services to specialized providers, thereby significantly boosting the growth of the services segment in the NIPT market.

“On the basis of the method type, ultrasound detection in the non-invasive prenatal testing (NIPT) market has accounted the largest market share in the forecast period.”

Based on the method type, the ultrasound detection segment of the non-invasive prenatal testing (NIPT) market accounted the largest market share in the forecast period. This growth is subjected to its dual functionality. Ultrasound not only assists in the visualization and monitoring of fetal development, enabling the detection of structural abnormalities, but also plays a crucial role in guiding other NIPT procedures, such as chorionic villus sampling (CVS) and amniocentesis. This combination of diagnostic and procedural support enhances the accuracy and reliability of NIPT, making ultrasound an indispensable tool in prenatal care and the preferred method for both clinicians and expectant parents.

“Based of application type, Trisomy is expected to witness the fastest CAGR in the non-invasive prenatal testing (NIPT) market.”

Trisomy segment is expected to witness the fastest CAGR in the non-invasive prenatal testing (NIPT) market. This growth is attributed to the increasing maternal age. As more women are choosing to have children later in life, the risk of chromosomal abnormalities such as trisomy syndromes increases. Older maternal age is associated with a higher likelihood of conditions like Down syndrome, prompting a greater need for reliable prenatal screening. This demographic shift leads to higher demand for NIPT, as it provides a safe, non-invasive option to detect trisomy syndromes early in the pregnancy, thereby contributing to the segment's accelerated growth.

“Based on end user type, hospitals segment accounted the second largest share in the non-invasive prenatal testing (NIPT) market.”

Hospitals segment holds the second largest market share in the non-invasive prenatal testing (NIPT) market primarily due to their comprehensive care capabilities and the integration of advanced diagnostic technologies. Hospitals offer a broad range of prenatal care services, including NIPT, which allows them to cater to a large volume of pregnant patients seeking reliable and non-invasive methods for detecting genetic abnormalities. The presence of specialized departments, experienced healthcare professionals, and advanced medical equipment in hospitals makes them a preferred choice for expectant mothers. Additionally, hospitals are often equipped to handle complex cases, further driving their significant share in the NIPT market.

“Based on Region, APAC is expected to witness the fastest CAGR in the under health during the forecast period.”

The Asia-Pacific (APAC) region is expected to witness the fastest Compound Annual Growth Rate (CAGR) in the non-invasive prenatal testing (NIPT) market primarily due to the increasing awareness and adoption of advanced healthcare technologies across the region. Rapid advancements in medical technology, coupled with rising disposable incomes and improvements in healthcare infrastructure, have significantly contributed to the growing demand for non-invasive prenatal testing. Additionally, the expanding healthcare coverage and government initiatives aimed at reducing infant mortality and improving maternal health have further driven the uptake of NIPT services. As more expectant parents become aware of the benefits of NIPT, such as its accuracy and safety compared to invasive procedures, the market is experiencing accelerated growth in APAC countries.

Key Market Players:

Prominent players in the non-invasive prenatal testing (NIPT) market include Illumina, Inc. (US), Natera, Inc. (US), Laboratory Corporation of America Holdings (US), Eurofins Sceintific (France), F. Hoffmann-La Roche AG (Switzerland). Revvity, Inc. (US), Thermo Fisher Scientific Inc (US), Agilent Technologies (US), GE Healthcare Technologies Inc. (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Centogene N.V. (Germany), Qiagen N.V. (Germany), Pathwest Laboratory Medicine WA (Australia), Myriad Genetics Inc. (US).

Don’t miss out on business opportunities in Non-invasive Prenatal Testing (NIPT) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]